CNSY (Cerenome) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNSY Cerenome Inc CNSY
29 GF Score
Price $2.02
! 1 Warning Sign
View Full Analysis

What is Cerenome Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cerenome  (NAS:CNSY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cerenome Cyclically Adjusted PB Ratio Related Terms


Cerenome Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Cerenome's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cerenome Cyclically Adjusted PB Ratio Chart

Cerenome Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cerenome Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CNSY vs JSPR, MRKR, ALLR: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Cerenome's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cerenome Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cerenome's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cerenome's Cyclically Adjusted PB Ratio falls into.


CNSY
29GF Score
Cerenome Inc CNSY
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cerenome Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cerenome's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Cerenome's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.747/333.9520*333.9520
=0.747

Current CPI (Jun. 2026) = 333.9520.

Cerenome Quarterly Data

Book Value per Share CPI Adj_Book
201609 125,060.575 241.428 172,988.341
201612 94,890.616 241.432 131,253.980
201703 58,086.335 243.801 79,565.087
201706 63,178.099 244.955 86,131.953
201709 42,229.780 246.819 57,137.901
201712 42,152.516 246.524 57,101.609
201803 25,805.908 249.554 34,533.346
201806 14,423.651 251.989 19,115.148
201809 9,843.864 252.439 13,022.465
201812 6,605.919 251.233 8,780.932
201903 3,301.352 254.202 4,337.075
201906 -5,311.238 256.143 -6,924.642
201909 21.115 256.759 27.463
201912 112.096 256.974 145.675
202003 8.214 258.115 10.627
202006 289.551 257.797 375.086
202009 214.068 260.280 274.660
202012 168.413 260.474 215.921
202103 350.412 264.877 441.793
202106 370.578 271.696 455.492
202109 360.229 274.310 438.552
202112 261.992 278.802 313.817
202203 354.013 287.504 411.206
202206 161.542 296.311 182.063
202209 131.302 296.808 147.734
202212 71.928 296.797 80.932
202303 27.779 301.836 30.735
202306 23.111 305.109 25.296
202309 14.494 307.789 15.726
202312 -7.451 306.746 -8.112
202403 -28.358 312.332 -30.321
202406 -33.418 314.175 -35.522
202409 -21.937 315.301 -23.235
202412 -37.943 315.605 -40.149
202503 -34.767 319.799 -36.306
202506 0.823 322.561 0.852
202509 0.960 324.800 0.987
202512 0.720 324.054 0.742
202603 2.152 330.213 2.176
202606 0.747 333.952 0.747

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cerenome Business Description

Other Exchanges XMP1:Germany
Address 6420 Levit Green Boulevard, Suite 210, Houston, TX, USA, 77021
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
29GF Score

Get the complete analysis for CNSY

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.02
Price